LEUKOTRIENE B-4 GENERATION AND DNA FRAGMENTATION INDUCED BY LEUKOCIDIN FROM STAPHYLOCOCCUS-AUREUS - PROTECTIVE ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND G-CSF FOR HUMAN NEUTROPHILS

被引:42
作者
HENSLER, T
KONIG, B
PREVOST, G
PIEMONT, Y
KOLLER, M
KONIG, W
机构
[1] RUHR UNIV BOCHUM,LEHRSTUHL MED MIKROBIOL & IMMUNOL,ARBEITSGRUPPE INFEKTABWEHRMECH,D-44780 BOCHUM,GERMANY
[2] UNIV STRASBOURG 1,FAC MED 3,BACTERIOL LAB,F-67000 STRASBOURG,FRANCE
关键词
D O I
10.1128/IAI.62.6.2529-2535.1994
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the effect of leukocidin from Staphylococcus aureus V8 strains (Luk-PV) on the generation of Leukotriene B-4 (LTB(4)) and its metabolites from human polymorphonuclear neutrophils (PMNs). Significant amounts of LTB(4) were generated by PMNs after leukocidin exposure in a time- and dose-dependent manner, as shown by reversed-phase high-performance liquid chromatography analysis. In this regard, the S and F components of leukocidin acted synergistically. The calcium ionophore A23187 induced LTB(4) generation, and the metabolism of exogenously added LTB(4) into biologically less active omega-oxidated compounds was significantly decreased after leukocidin exposure. Priming of PMNs with granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF prior to leukocidin exposure substantially increased toxin- and calcium ionophore A23187-induced LTB(4) formation. The inhibitory effects of leukocidin on mediator release were accompanied by membrane damage and DNA fragmentation, which were both restored after pretreatment with GM-CSF. The data suggest that the presence of costimulatory priming factors such as GM-CSF or G-CSF in the microenvironment of an inflammatory focus determines the pathophysiological effects induced by S. aureus leukocidin.
引用
收藏
页码:2529 / 2535
页数:7
相关论文
共 36 条
[1]  
Bainton D.F., 1988, INFLAMMATION BASIC P, P265
[2]   INTERLEUKIN-3 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR RENDER HUMAN BASOPHILS RESPONSIVE TO LOW CONCENTRATIONS OF COMPLEMENT COMPONENT-C3A [J].
BISCHOFF, SC ;
DEWECK, AL ;
DAHINDEN, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6813-6817
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]   LEUKOTRIENES IN INFLAMMATION [J].
BRAY, MA .
AGENTS AND ACTIONS, 1986, 19 (1-2) :87-99
[5]   EFFECT OF THIOL-ACTIVATED TOXINS (STREPTOLYSIN O, ALVEOLYSIN, AND THETA TOXIN) ON THE GENERATION OF LEUKOTRIENES AND LEUKOTRIENE-INDUCING AND LEUKOTRIENE-METABOLIZING ENZYMES FROM HUMAN POLYMORPHONUCLEAR GRANULOCYTES [J].
BREMM, KD ;
KONIG, W ;
PFEIFFER, P ;
RAUSCHEN, I ;
THEOBALD, K ;
THELESTAM, M ;
ALOUF, JE .
INFECTION AND IMMUNITY, 1985, 50 (03) :844-851
[6]  
BROM J, 1988, IMMUNOLOGY, V64, P509
[7]   STAPHYLOCOCCUS-AUREUS LEUKOCIDIN - A NEW VIRULENCE FACTOR IN CUTANEOUS INFECTIONS - AN EPIDEMIOLOGIC AND EXPERIMENTAL-STUDY [J].
CRIBIER, B ;
PREVOST, G ;
COUPPIE, P ;
FINCKBARBANCON, V ;
GROSSHANS, E ;
PIEMONT, Y .
DERMATOLOGY, 1992, 185 (03) :175-180
[8]   LEUKOTRIENE PRODUCTION IN HUMAN-NEUTROPHILS PRIMED BY RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND STIMULATED WITH THE COMPLEMENT COMPONENT C5A AND FMLP AS 2ND SIGNALS [J].
DAHINDEN, CA ;
ZINGG, J ;
MALY, FE ;
DEWECK, AL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1281-1295
[9]  
ELIOTT MJ, 1989, BLOOD, V74, P2349
[10]   IMPROVED PURIFICATION OF LEUKOCIDIN FROM STAPHYLOCOCCUS-AUREUS AND TOXIN DISTRIBUTION AMONG HOSPITAL STRAINS [J].
FINCKBARBANCON, V ;
PREVOST, G ;
PIEMONT, Y .
RESEARCH IN MICROBIOLOGY, 1991, 142 (01) :75-85